Skip to main content

Advertisement

ADVERTISEMENT

News

ActiGraft - RedDress 

https://www.globenewswire.com/en/news-release/2024/09/03/2939626/0/en/RedDress-Announces-Randomized-Controlled-Trial-Results-Showing-Significant-Benefits-of-ActiGraft-Pro-for-Diabetic-Foot-Ulcers.html

RedDress announced that ActiGraft Pro demonstrated exceptional efficacy in facilitating healing for chronic neuropathic DFUs. ActiGraft Pro showed significant superiority, with 2.73 greater odds of reaching complete wound closure by week 12 compared to the control (SoC).

Advertisement

Advertisement

Advertisement